Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter randomized open-label safety comparison of tigecycline versus beta-lactam/beta-lactamase inhibitor regimens in complicated skin and skin structure infections
2005-004250-28Phase 4Completed
- Sponsor
- Wyeth
- Start
- Aug 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tigecycline in Complicated skin and skin structure infection (cSSSI) (3 arms), sponsored by Wyeth. Started Aug 2006; status: completed.
02
Drugs
tigecycline
03
Conditions
Complicated skin and skin structure infection (cSSSI)
Beyond the preview
Go deeper on 2005-004250-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004250-28.